Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington’s Disease Franchise
Arexera Therapeutics, Inc. ("Arexera"), formerly Atalanta Therapeutics, a biotechnology company developing small interfering RNA (siRNA) medicines for severe neurological diseases, today unveiled a new name and corporate identity reflecting its…
Read more